ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Community Cancer Centers RFP Issued; Advisors Criticize Project Structure.

November 10, 2006

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

FDA Approves Imaging System To Detect Cervical Pre-Cancer

March 31, 2006

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

Continuing Resolution Funds Agencies Through Dec. 5.

November 17, 2000